Follow
Aysegul Balyimez, PhD
Aysegul Balyimez, PhD
Verified email at ccf.org
Title
Cited by
Cited by
Year
Transcriptomic and protein analysis of small-cell bladder cancer (SCBC) identifies prognostic biomarkers and DLL3 as a relevant therapeutic target
VS Koshkin, JA Garcia, J Reynolds, P Elson, C Magi-Galluzzi, ...
Clinical Cancer Research 25 (1), 210-221, 2019
562019
Identification of gene expression determinants of radiosensitivity in bladder cancer (BC) cell lines.
J Pettiford, S Rashid, A Balyimez, T Radivoyevitch, VS Koshkin, ...
Journal of Clinical Oncology 36 (15_suppl), e16507-e16507, 2018
52018
Characterization of the Pseudomonas aeruginosametalloendopeptidase, Mep72, a member of the Vfr regulon
A Balyimez, JA Colmer-Hamood, M San Francisco, AN Hamood
BMC microbiology 13, 1-13, 2013
42013
Correlation between gene expression and prognostic biomarkers in small cell bladder cancer (SCBC).
VS Koshkin, A Dhawan, M Hu, J Reynolds, P Elson, J McKenney, ...
Journal of Clinical Oncology 36 (15_suppl), 4546-4546, 2018
32018
PD14-01 ORTHOTOPIC MURINE MODEL OF NEUROENDOCRINE BLADDER CANCER ELUCIDATES POTENTIAL MOLECULAR DRIVERS OF SMALL CELL BLADDER CANCER (SCBC)
R Liao, J Imamura, HT Ruan Li, A Muskara, S Ganguly, C McFarland, ...
The Journal of Urology 211 (5S), e353, 2024
2024
A NOVEL ORTHOTOPIC MURINE MODEL OF NEUROENDOCRINE BLADDER CANCER: INSIGHTS INTO THE MOLECULAR DRIVERS OF SMALL CELL BLADDER CANCER (SCBC)
R Liao, J Imamura, A Muskara, S Ganguly, A Balyimez, M Ornstein, ...
Urologic Oncology: Seminars and Original Investigations 42, S31, 2024
2024
Methyl-CpG Binding Domain Protein MBD2 Is a Targetable Vulnerability in TET2 Mutant Myeloid Neoplasia
D Jiang, Y Guan, S Ganguly, A Balyimez, A Muskara, DJ Singh, ...
Blood 142, 2766, 2023
2023
Differentiating bladder cancer (BLCA) tumor immune microenvironment (TME) profiles based on predicted intrinsic radiosensitivity (RS).
W Vuong, S Ganguly, A Balyimez, A Halima, C Kerr, ML Day, SA Tomlins, ...
Journal of Clinical Oncology 41 (16_suppl), e16622-e16622, 2023
2023
Identification of Putative Gene-Target Modulators of Radiosensitivity in Bladder Cancer Cell Lines (BlaCCL)
W Vuong, SY Ganguly, A Balyimez, A Halima, C Kerr, B Lee, EA Klein, ...
International Journal of Radiation Oncology, Biology, Physics 111 (3), e257, 2021
2021
Transcriptomic and Mutational Analyses Identify Biological Processes Correlated with Bladder Cancer Cell Line (BlaCCL) Radiation Response
W Vuong, A Balyimez, SY Ganguly, S Laximi, C Kerr, B Lee, EA Klein, ...
International Journal of Radiation Oncology, Biology, Physics 108 (3), e571, 2020
2020
A Common Polymorphism in 3β-hydroxysteroid Dehydrogenase Promotes Resistance to Radiotherapy
OY Mian, SY Ganguly, A Balyimez, Z Lone, P Wilkinson, A Hardaway, ...
International Journal of Radiation Oncology, Biology, Physics 108 (3), S41, 2020
2020
The BET inhibitor JQ-1 enhances radio-sensitivity in pediatric cancer cell lines by sustained p-gH2AX expression and enhanced differentiation
TM Abou-Antoun, J Abdallah, AR Khater, S El-Soussi, A Balyimez, ...
Cancer Research 80 (16_Supplement), 1746-1746, 2020
2020
Extragonadal and regional androgen biosynthesis associated with a common steroidogenic enzyme polymorphism promotes radioresistance in prostate cancer
S Ganguly, A Balyimez, Z Lone, A Hardaway, M Patel, E Davicioni, ...
Cancer Research 80 (16_Supplement), 2082-2082, 2020
2020
An orthotopic murine model of neuroendocrine bladder cancer offers insights into the phenotypic plasticity of small cell bladder cancer (SCBC)
A Balyimez, S Ganguly, S Thirunavukkarasu, P Grivas, M Ornstein, ...
Cancer Research 80 (16_Supplement), 436-436, 2020
2020
Methyl CpG Binding Protein 2 suppresses Myc targeting miRNAs to promote context dependent tumor proliferation
A Balyimez, Y Guan, E Esakov, S Ganguly, O Reizes, DJ Lindner, ...
Cancer Research 80 (16_Supplement), 2450-2450, 2020
2020
Circulating cell-free DNA (cfDNA) levels and fragmentation patterns discriminate muscle invasive from non-muscle invasive urothelial cancer of the bladder
S Ganguly, J Fallah, H Li, W Wei, A Balyimez, CM Diaz, P Rayman, ...
Cancer Research 80 (16_Supplement), 1159-1159, 2020
2020
Tumor cell intrinsic androgen biosynthesis by 3β-hydroxy steroid dehydrogenase (HSD3B1) to modulate radiosensitivity in prostate cancer cells.
S Ganguly, A Balyimez, Z Lone, A Hardaway, M Patel, E Davicioni, ...
Journal of Clinical Oncology 38 (6_suppl), 349-349, 2020
2020
A novel orthotopic murine model of neuroendocrine bladder cancer: Insights into the phenotypic plasticity of small cell bladder cancer (SCBC).
A Balyimez, S Ganguly, P Grivas, MC Ornstein, S Gupta, JA Garcia, ...
Journal of Clinical Oncology 38 (6_suppl), 571-571, 2020
2020
The landscape of early carcinogenesis revealed through the lens of integrative genomics, epigenomics, and transcriptomics
A Balyimez, KL Stephans, ME Abazeed, OY Mian
Journal of Thoracic Disease 11 (6), 2188, 2019
2019
Association of cell-free DNA (cfDNA) levels with myeloid-derived suppressor cells (MDSC) levels in blood of patients (pts) with muscle invasive (MI) and metastatic (met …
J Fallah, S Ganguly, PA Rayman, W Wei, A Balyimez, T Sitalaximi, ...
Journal of Clinical Oncology 37 (15_suppl), 4528-4528, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20